<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study analyzed factors associated with <z:hpo ids='HP_0011009'>acute</z:hpo> oropharyngeal <z:e sem="disease" ids="C0019348" disease_type="Disease or Syndrome" abbrv="">herpes simplex</z:e> virus (HSV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in 627 patients who had undergone allogeneic bone marrow transplantation for <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, or <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1504513" disease_type="Disease or Syndrome" abbrv="">HSV infection</z:e> developed in 233 (37%) of the patients; <z:hpo ids='HP_0000001'>all</z:hpo> but two were seropositive for HSV before transplant </plain></SENT>
<SENT sid="2" pm="."><plain>Sixty-two percent of the seropositive patients had at least one episode of HSV reactivation during the first 100 days after transplant </plain></SENT>
<SENT sid="3" pm="."><plain>Other factors that placed patients at increased risk for <z:e sem="disease" ids="C1504513" disease_type="Disease or Syndrome" abbrv="">HSV infection</z:e> were a pretransplant diagnosis of <z:hpo ids='HP_0001909'>leukemia</z:hpo>, being in remission at the time of transplant, and/or having been conditioned for transplant with chemoradiotherapy </plain></SENT>
<SENT sid="4" pm="."><plain>Recognition of factors that may predispose patients to <z:e sem="disease" ids="C1504513" disease_type="Disease or Syndrome" abbrv="">HSV infection</z:e> helps determine those transplant recipients who might benefit most from antiviral prophylaxis or other approaches to prevention of HSV reactivation </plain></SENT>
</text></document>